S100B and tuberculosis: The activation of B-cells by the Mtb specific HLA-E restricted CD8+ T-cells could be of potential benefit when utilizing this non-classical antigen presentation pathway in TB vaccination strategies, next to its limited allelic variation and its resistance to HIV-nef mediated downregulation.